EKSO BIONICS HOLDINGS, INC.·4

Feb 22, 7:33 PM ET

Shaw William R 4

4 · EKSO BIONICS HOLDINGS, INC. · Filed Feb 22, 2022

Insider Transaction Report

Form 4
Period: 2022-02-17
Shaw William R
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2022-02-17+17,94396,943 total
Footnotes (1)
  • [F1]Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION